“…Homozygous or heterozygous variants were completely absent in all individuals studied and with only the wild type genotype being expressed an OR for risk was not estimable. One relevant study was identified for genes variants IL-1α (C889T) [45], CYP11B2 (C344T) [46], ESR1 (PVUII and XbaI) [47], α ADD1 (WG) [33], TNF α (G488A and G308A) [48], CYP4F2 (G1347A) [49], MDR-1 [50], t-PA (C7351T and I/D) [51], PAI-1 (4G/5G) [51], CBS (T833C) [52], Klotho (KL-VS and C1818T) [53], Factor XIIIB (V34L) [54], α1 antichymotrypsin (Ala15Thr) [55] and MMP3 (5A/6A) [48]. Of these IL-1α, CYP11B2, ESR1 (PVUII), α ADD1, TNF α (G488A), CYP4F2, MDR-1 and t-PA (I/D) were found to be significantly associated with ischemic stroke (Table S1).…”